APA (7th ed.) Citation

K, K., AR, Y., K, O., HS, H., JY, L., SW, H., . . . BD, Y. (2026). Association of early vedolizumab trough levels with clinical, biochemical, endoscopic response and drug optimization during maintenance therapy in patients with inflammatory bowel diseases. Scientific reports, 16(1), . https://doi.org/10.1038/s41598-026-39413-7

Chicago Style (17th ed.) Citation

K, Kim, et al. "Association of Early Vedolizumab Trough Levels with Clinical, Biochemical, Endoscopic Response and Drug Optimization During Maintenance Therapy in Patients with Inflammatory Bowel Diseases." Scientific Reports 16, no. 1 (2026). https://doi.org/10.1038/s41598-026-39413-7.

MLA (9th ed.) Citation

K, Kim, et al. "Association of Early Vedolizumab Trough Levels with Clinical, Biochemical, Endoscopic Response and Drug Optimization During Maintenance Therapy in Patients with Inflammatory Bowel Diseases." Scientific Reports, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41598-026-39413-7.